No abuse of dominance by pharma-Co. as there were a number of other pharma-Cos. having higher sales than OP

COMPETITION LAW : Where informant drug dealer merely asserting that OP imposed unfair conditions in dealing with it, however, sales data across pharmaceutical companies showed that there were a number of pharmaceutical companies have higher sales than OP and as such OP did not seem to enjoy dominant position, question of alleged abusive conduct by OP within meaning of provisions of section 4, did not arise

from www.taxmann.com Latest Case Laws https://ift.tt/393mFo8